"There was no cause to grant Pfizer full approval", Prof. Peter McCullough

"There was no cause to grant Pfizer full approval", Prof. Peter McCullough

Publié le 02/09/2021 à 17:28
FS
PARTAGER CET ARTICLE :
Auteur(s): FranceSoir

Cet espace d’opinion permet la libre expression des idées et d’engendrer le débat. Les articles et vidéos publiés dans cette rubrique peuvent parfois ne pas faire consensus, en savoir plus

-A +A

Professor McCullough has done France Soir the honour of speaking to our audience on several recent occasions, latterly in relation to purportedly scientific utterances from the French President, in his address to the Nation on 12th July. At the time, the Professor had pointed to the notoriously unstable foundation for those statements.

Updated 30th August : the sub-titles have been amended to strike out a Zero which appeared by error in two separate places in the sub-titles.

After days of rumour and speculation, on 23rd August 2021 the FDA issued full approval to the Pfizer-BioNTech (Comirnaty) injection for persons aged over 16 ; that said, the FDA did nevertheless require the labs to carry out a number of further trials.

Cf : Analysis of President Macron's scientific assertions by Professor Peter McCullough

Professor McCullough has kindly accepted to comment the decision.

Inter alia, the Professor notes that the labs have presented very little fresh data. As for the data they did present, most pertains to the native strain of Sars-Cov-2 against which the injections were allegedly developed. That strain would no longer appear to be circulating, while the appearance of the Delta variant change casts serious doubt upon the injections' further usefulness.

Strangely enough, says Professor McCullough, and despite safety-data issues that have been raised internationally, the FDA would appear to have simply let slide the requirement that Pfizer-BioNTech present reports on biodistribution, immunology, toxicity, genotoxicity … need one continue ?

What is more, good practice would dictate that the FDA grant full approval to a medicinal substance such as a vaccine only once ten to twenty years have elapsed, during which full studies will have taken place. Here, we have a laboratory being rewarded with full approval after but a few short months, quite literally for the first time in the history of medecine – meanwhile back at the ranch, adverse-effect reports continue to pour in, with myocarditis and pericarditis leading the wolf-pack.

Stranger yet, the fact that while still under Emergency Use Authorisation, the substances being trialed have been injected into hundreds of millions of people, again, for the first time in the history of medecine.

As the authorities persist in touting the injections' « efficiency », evidence from several heavily-vaccinated countries mounts day by day that the injections protect neither against infection, nor against hospitalisation, nor even do they prevent death.

Professor McCullough notes that patients are not being informed of the peculiarities of each vaccine : for example, the injections do not contain an identical quantity of mRNA, which factor which may also have an impact on their efficiency.

To sum up, the Professor believes that a short sharp chop should have been given to the injection campaign as early as February 2021. The FDA, the CDC and their counterparts abroad have failed to take into account an avalanche of dreadful adverse effects, including thousands of deaths. In his view, an independent body should be systematically recording all such cases, and investigating the thousands of « unexplained accidents » where suspicion may legitimately be cast on the injections.

Auteur(s): FranceSoir

PARTAGER CET ARTICLE :

Chère lectrice, cher lecteur,
Vous avez lu et apprécié notre article et nous vous en remercions. Pour que nous puissions poursuivre notre travail d’enquête et d’investigation, nous avons besoin de votre aide. FranceSoir est différent de la plupart des medias Français :
- Nous sommes un média indépendant, nous n’appartenons ni à un grand groupe ni à de grands chefs d’entreprises, de ce fait, les sujets que nous traitons et la manière dont nous le faisons sont exempts de préjugés ou d’intérêts particuliers, les analyses que nous publions sont réalisées sans crainte des éventuelles pressions de ceux qui ont le pouvoir.
- Nos journalistes et contributeurs travaillent en collectif, au dessus des motivations individuelles, dans l’objectif d’aller à la recherche du bon sens, à la recherche de la vérité dans l’intérêt général.
- Nous avons choisi de rester gratuit pour tout le monde, afin que chacun ait la possibilité de pouvoir accéder à une information libre et de qualité indépendamment des ressources financières de chacun.

C’est la raison pour laquelle nous sollicitons votre soutien. Vous êtes de plus en plus nombreux à nous lire et nous donner des marques de confiance, ce soutien est précieux, il nous permet d’asseoir notre légitimité de media libre et indépendant et plus vous nous lirez plus nous aurons un impact dans le bruit médiatique ambiant.
Alors si vous souhaitez nous aider, c’est maintenant. Vous avez le pouvoir de participer au développement de FranceSoir et surtout faire en sorte que nous poursuivions notre mission d’information. Chaque contribution, petite ou grande, est importante pour nous, elle nous permet d'investir sur le long terme. Toute l’équipe vous remercie.




Prof. Peter McCullough

Newsletter





Commentaires

-

Je m'abonne à la Newsletter FranceSoir